Major Step Toward Precision Medicine for Malignant Brain Tumors
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)
GENDER: All
HEALTHY PARTICIPANTS: No
LOCATION: UH Seidman Cancer Center
Learn More About This Research Study
For more information, please contact Carmen Whatley, RN, the study coordinator at 855-948-3462 or complete the online form below.
Purpose of Study
The purpose of this study is to evaluate multiple investigational treatments for either newly diagnosed or recurrent glioblastoma to determine if any of these investigational treatments(s) improve how long patients live (overall survival) as compared to standard treatments. The study design allows multiple therapies and combinations of therapies to be screened simultaneously and over time.
Who Can Participate?
Patients 18 years or older who have been newly diagnosed with glioblastoma (GBM) or recurrent GBM may be eligible to participate in the study.